カテゴリー： 世界, 医療/バイオ, LP Information

世界の止血剤＆組織シーラント剤市場予測 2023年-2029年

【英語タイトル】Global Hemostats and Tissue Sealants Market Growth 2023-2029

LP Informationが出版した調査資料（LP23MY4849）・商品コード：LP23MY4849
・発行会社（調査会社）：LP Information
・発行日：2023年5月
・ページ数：95
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の止血剤＆組織シーラント剤市場」は、過去の販売実績から2022年の世界の止血剤＆組織シーラント剤の総販売量を検討し、2023年から2029年の予測される止血剤＆組織シーラント剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の止血剤＆組織シーラント剤の市場規模を掲載し、XXX百万米ドル規模の世界の止血剤＆組織シーラント剤市場の詳細な分析を提供します。本インサイトレポートは、世界の止血剤＆組織シーラント剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の止血剤＆組織シーラント剤市場における各社の独自のポジションをより深く理解するために、止血剤＆組織シーラント剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の止血剤＆組織シーラント剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。止血剤＆組織シーラント剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。止血剤＆組織シーラント剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。止血剤＆組織シーラント剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

止血剤＆組織シーラント剤の世界主要メーカーとしては、Baxter、 CR Bard、 Johnson & Johnson、 B.Braun、 Cardinal Health、 Cryolife、 Neomend、 Vivostat、 Z-Medicaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の止血剤＆組織シーラント剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では止血剤＆組織シーラント剤市場をセグメンテーションし、種類別 (止血剤、組織シーラント剤)、用途別 (臨床医学、科学研究)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：止血剤、組織シーラント剤

・用途別区分：臨床医学、科学研究

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の止血剤＆組織シーラント剤市場の10年間の市場状況・展望は？
・世界および地域別に見た止血剤＆組織シーラント剤市場成長の要因は何か？
・止血剤＆組織シーラント剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・止血剤＆組織シーラント剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：止血剤＆組織シーラント剤の年間販売量2018-2029、地域別現状・将来分析
・止血剤＆組織シーラント剤の種類別セグメント：止血剤、組織シーラント剤
・止血剤＆組織シーラント剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・止血剤＆組織シーラント剤の用途別セグメント：臨床医学、科学研究
・止血剤＆組織シーラント剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の止血剤＆組織シーラント剤市場
・企業別のグローバル止血剤＆組織シーラント剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別の止血剤＆組織シーラント剤の年間売上：2018-2023年の売上、市場シェア
・企業別の止血剤＆組織シーラント剤販売価格
・主要企業の止血剤＆組織シーラント剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

止血剤＆組織シーラント剤の地域別レビュー
・地域別の止血剤＆組織シーラント剤市場規模2018-2023：年間販売量、売上
・主要国別の止血剤＆組織シーラント剤市場規模2018-2023：年間販売量、売上
・南北アメリカの止血剤＆組織シーラント剤販売の成長
・アジア太平洋の止血剤＆組織シーラント剤販売の成長
・ヨーロッパの止血剤＆組織シーラント剤販売の成長
・中東・アフリカの止血剤＆組織シーラント剤販売の成長

南北アメリカ市場
・南北アメリカの国別の止血剤＆組織シーラント剤販売量、売上（2018-2023）
・南北アメリカの止血剤＆組織シーラント剤の種類別販売量
・南北アメリカの止血剤＆組織シーラント剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の止血剤＆組織シーラント剤販売量、売上（2018-2023）
・アジア太平洋の止血剤＆組織シーラント剤の種類別販売量
・アジア太平洋の止血剤＆組織シーラント剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の止血剤＆組織シーラント剤販売量、売上（2018-2023）
・ヨーロッパの止血剤＆組織シーラント剤の種類別販売量
・ヨーロッパの止血剤＆組織シーラント剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の止血剤＆組織シーラント剤販売量、売上（2018-2023）
・中東・アフリカの止血剤＆組織シーラント剤の種類別販売量
・中東・アフリカの止血剤＆組織シーラント剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・止血剤＆組織シーラント剤の製造コスト構造分析
・止血剤＆組織シーラント剤の製造プロセス分析
・止血剤＆組織シーラント剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・止血剤＆組織シーラント剤の主要なグローバル販売業者
・止血剤＆組織シーラント剤の主要なグローバル顧客

地域別の止血剤＆組織シーラント剤市場予測レビュー
・地域別の止血剤＆組織シーラント剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・止血剤＆組織シーラント剤の種類別市場規模予測
・止血剤＆組織シーラント剤の用途別市場規模予測

主要企業分析
Baxter、 CR Bard、 Johnson & Johnson、 B.Braun、 Cardinal Health、 Cryolife、 Neomend、 Vivostat、 Z-Medica
・企業情報
・止血剤＆組織シーラント剤製品
・止血剤＆組織シーラント剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Blood clotting or coagulation, is an important process that eliminates excessive bleeding when a blood vessel is damaged. Platelets and proteins work together to stop the bleeding by forming a clot over the injury. Blood clottage is one of the mechanisms that reduce the loss of blood from damaged blood vessels. Hemostats and tissue sealants are used post-surgery or traumatic injury to bind or hold external tissue (skin) as well as internal tissue (blood vessels). Some key types of hemostats and tissue sealants include fibrin sealants, collagen-based compounds, synthetic agents, and tissue adhesive glues such as hydrogels and glutaraldehyde glues. Fibrin sealants have a wide range of medical applications.
LPI (LP Information)’ newest research report, the “Hemostats and Tissue Sealants Industry Forecast” looks at past sales and reviews total world Hemostats and Tissue Sealants sales in 2022, providing a comprehensive analysis by region and market sector of projected Hemostats and Tissue Sealants sales for 2023 through 2029. With Hemostats and Tissue Sealants sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemostats and Tissue Sealants industry.
This Insight Report provides a comprehensive analysis of the global Hemostats and Tissue Sealants landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemostats and Tissue Sealants portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hemostats and Tissue Sealants market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemostats and Tissue Sealants and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemostats and Tissue Sealants.
The global Hemostats and Tissue Sealants market size is projected to grow from US$ 3211.1 million in 2022 to US$ 4900.2 million in 2029; it is expected to grow at a CAGR of 4900.2 from 2023 to 2029.
The recent increase in number of out-patient surgeries is the prime driver for the growth of this market. Since these surgeries help to reduce the overall healthcare expenditure, they are increasingly being preferred by insurance payers to acquire reimbursements for their surgeries. Furthermore, as the out-patient surgeries do not require overnight stays, they are readily available to the patients.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemostats and Tissue Sealants market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Hemostats
Tissue Sealants
Segmentation by application
Clinical Medicine
Scientific Research
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Baxter
CR Bard
Johnson & Johnson
B.Braun
Cardinal Health
Cryolife
Neomend
Vivostat
Z-Medica
Key Questions Addressed in this Report
What is the 10-year outlook for the global Hemostats and Tissue Sealants market?
What factors are driving Hemostats and Tissue Sealants market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Hemostats and Tissue Sealants market opportunities vary by end market size?
How does Hemostats and Tissue Sealants break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hemostats and Tissue Sealants Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hemostats and Tissue Sealants by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hemostats and Tissue Sealants by Country/Region, 2018, 2022 & 2029
2.2 Hemostats and Tissue Sealants Segment by Type
2.2.1 Hemostats
2.2.2 Tissue Sealants
2.3 Hemostats and Tissue Sealants Sales by Type
2.3.1 Global Hemostats and Tissue Sealants Sales Market Share by Type (2018-2023)
2.3.2 Global Hemostats and Tissue Sealants Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hemostats and Tissue Sealants Sale Price by Type (2018-2023)
2.4 Hemostats and Tissue Sealants Segment by Application
2.4.1 Clinical Medicine
2.4.2 Scientific Research
2.5 Hemostats and Tissue Sealants Sales by Application
2.5.1 Global Hemostats and Tissue Sealants Sale Market Share by Application (2018-2023)
2.5.2 Global Hemostats and Tissue Sealants Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hemostats and Tissue Sealants Sale Price by Application (2018-2023)
3 Global Hemostats and Tissue Sealants by Company
3.1 Global Hemostats and Tissue Sealants Breakdown Data by Company
3.1.1 Global Hemostats and Tissue Sealants Annual Sales by Company (2018-2023)
3.1.2 Global Hemostats and Tissue Sealants Sales Market Share by Company (2018-2023)
3.2 Global Hemostats and Tissue Sealants Annual Revenue by Company (2018-2023)
3.2.1 Global Hemostats and Tissue Sealants Revenue by Company (2018-2023)
3.2.2 Global Hemostats and Tissue Sealants Revenue Market Share by Company (2018-2023)
3.3 Global Hemostats and Tissue Sealants Sale Price by Company
3.4 Key Manufacturers Hemostats and Tissue Sealants Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hemostats and Tissue Sealants Product Location Distribution
3.4.2 Players Hemostats and Tissue Sealants Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hemostats and Tissue Sealants by Geographic Region
4.1 World Historic Hemostats and Tissue Sealants Market Size by Geographic Region (2018-2023)
4.1.1 Global Hemostats and Tissue Sealants Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hemostats and Tissue Sealants Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hemostats and Tissue Sealants Market Size by Country/Region (2018-2023)
4.2.1 Global Hemostats and Tissue Sealants Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hemostats and Tissue Sealants Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hemostats and Tissue Sealants Sales Growth
4.4 APAC Hemostats and Tissue Sealants Sales Growth
4.5 Europe Hemostats and Tissue Sealants Sales Growth
4.6 Middle East & Africa Hemostats and Tissue Sealants Sales Growth
5 Americas
5.1 Americas Hemostats and Tissue Sealants Sales by Country
5.1.1 Americas Hemostats and Tissue Sealants Sales by Country (2018-2023)
5.1.2 Americas Hemostats and Tissue Sealants Revenue by Country (2018-2023)
5.2 Americas Hemostats and Tissue Sealants Sales by Type
5.3 Americas Hemostats and Tissue Sealants Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hemostats and Tissue Sealants Sales by Region
6.1.1 APAC Hemostats and Tissue Sealants Sales by Region (2018-2023)
6.1.2 APAC Hemostats and Tissue Sealants Revenue by Region (2018-2023)
6.2 APAC Hemostats and Tissue Sealants Sales by Type
6.3 APAC Hemostats and Tissue Sealants Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hemostats and Tissue Sealants by Country
7.1.1 Europe Hemostats and Tissue Sealants Sales by Country (2018-2023)
7.1.2 Europe Hemostats and Tissue Sealants Revenue by Country (2018-2023)
7.2 Europe Hemostats and Tissue Sealants Sales by Type
7.3 Europe Hemostats and Tissue Sealants Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hemostats and Tissue Sealants by Country
8.1.1 Middle East & Africa Hemostats and Tissue Sealants Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hemostats and Tissue Sealants Revenue by Country (2018-2023)
8.2 Middle East & Africa Hemostats and Tissue Sealants Sales by Type
8.3 Middle East & Africa Hemostats and Tissue Sealants Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hemostats and Tissue Sealants
10.3 Manufacturing Process Analysis of Hemostats and Tissue Sealants
10.4 Industry Chain Structure of Hemostats and Tissue Sealants
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hemostats and Tissue Sealants Distributors
11.3 Hemostats and Tissue Sealants Customer
12 World Forecast Review for Hemostats and Tissue Sealants by Geographic Region
12.1 Global Hemostats and Tissue Sealants Market Size Forecast by Region
12.1.1 Global Hemostats and Tissue Sealants Forecast by Region (2024-2029)
12.1.2 Global Hemostats and Tissue Sealants Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hemostats and Tissue Sealants Forecast by Type
12.7 Global Hemostats and Tissue Sealants Forecast by Application
13 Key Players Analysis
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Hemostats and Tissue Sealants Product Portfolios and Specifications
13.1.3 Baxter Hemostats and Tissue Sealants Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 CR Bard
13.2.1 CR Bard Company Information
13.2.2 CR Bard Hemostats and Tissue Sealants Product Portfolios and Specifications
13.2.3 CR Bard Hemostats and Tissue Sealants Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 CR Bard Main Business Overview
13.2.5 CR Bard Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Hemostats and Tissue Sealants Product Portfolios and Specifications
13.3.3 Johnson & Johnson Hemostats and Tissue Sealants Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 B.Braun
13.4.1 B.Braun Company Information
13.4.2 B.Braun Hemostats and Tissue Sealants Product Portfolios and Specifications
13.4.3 B.Braun Hemostats and Tissue Sealants Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 B.Braun Main Business Overview
13.4.5 B.Braun Latest Developments
13.5 Cardinal Health
13.5.1 Cardinal Health Company Information
13.5.2 Cardinal Health Hemostats and Tissue Sealants Product Portfolios and Specifications
13.5.3 Cardinal Health Hemostats and Tissue Sealants Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cardinal Health Main Business Overview
13.5.5 Cardinal Health Latest Developments
13.6 Cryolife
13.6.1 Cryolife Company Information
13.6.2 Cryolife Hemostats and Tissue Sealants Product Portfolios and Specifications
13.6.3 Cryolife Hemostats and Tissue Sealants Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Cryolife Main Business Overview
13.6.5 Cryolife Latest Developments
13.7 Neomend
13.7.1 Neomend Company Information
13.7.2 Neomend Hemostats and Tissue Sealants Product Portfolios and Specifications
13.7.3 Neomend Hemostats and Tissue Sealants Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Neomend Main Business Overview
13.7.5 Neomend Latest Developments
13.8 Vivostat
13.8.1 Vivostat Company Information
13.8.2 Vivostat Hemostats and Tissue Sealants Product Portfolios and Specifications
13.8.3 Vivostat Hemostats and Tissue Sealants Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Vivostat Main Business Overview
13.8.5 Vivostat Latest Developments
13.9 Z-Medica
13.9.1 Z-Medica Company Information
13.9.2 Z-Medica Hemostats and Tissue Sealants Product Portfolios and Specifications
13.9.3 Z-Medica Hemostats and Tissue Sealants Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Z-Medica Main Business Overview
13.9.5 Z-Medica Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Hemostats and Tissue Sealants Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hemostats and Tissue Sealants Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Hemostats
Table 4. Major Players of Tissue Sealants
Table 5. Global Hemostats and Tissue Sealants Sales by Type (2018-2023) & (K Units)
Table 6. Global Hemostats and Tissue Sealants Sales Market Share by Type (2018-2023)
Table 7. Global Hemostats and Tissue Sealants Revenue by Type (2018-2023) & ($ million)
Table 8. Global Hemostats and Tissue Sealants Revenue Market Share by Type (2018-2023)
Table 9. Global Hemostats and Tissue Sealants Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Hemostats and Tissue Sealants Sales by Application (2018-2023) & (K Units)
Table 11. Global Hemostats and Tissue Sealants Sales Market Share by Application (2018-2023)
Table 12. Global Hemostats and Tissue Sealants Revenue by Application (2018-2023)
Table 13. Global Hemostats and Tissue Sealants Revenue Market Share by Application (2018-2023)
Table 14. Global Hemostats and Tissue Sealants Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Hemostats and Tissue Sealants Sales by Company (2018-2023) & (K Units)
Table 16. Global Hemostats and Tissue Sealants Sales Market Share by Company (2018-2023)
Table 17. Global Hemostats and Tissue Sealants Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Hemostats and Tissue Sealants Revenue Market Share by Company (2018-2023)
Table 19. Global Hemostats and Tissue Sealants Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Hemostats and Tissue Sealants Producing Area Distribution and Sales Area
Table 21. Players Hemostats and Tissue Sealants Products Offered
Table 22. Hemostats and Tissue Sealants Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hemostats and Tissue Sealants Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Hemostats and Tissue Sealants Sales Market Share Geographic Region (2018-2023)
Table 27. Global Hemostats and Tissue Sealants Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Hemostats and Tissue Sealants Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Hemostats and Tissue Sealants Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Hemostats and Tissue Sealants Sales Market Share by Country/Region (2018-2023)
Table 31. Global Hemostats and Tissue Sealants Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Hemostats and Tissue Sealants Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Hemostats and Tissue Sealants Sales by Country (2018-2023) & (K Units)
Table 34. Americas Hemostats and Tissue Sealants Sales Market Share by Country (2018-2023)
Table 35. Americas Hemostats and Tissue Sealants Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Hemostats and Tissue Sealants Revenue Market Share by Country (2018-2023)
Table 37. Americas Hemostats and Tissue Sealants Sales by Type (2018-2023) & (K Units)
Table 38. Americas Hemostats and Tissue Sealants Sales by Application (2018-2023) & (K Units)
Table 39. APAC Hemostats and Tissue Sealants Sales by Region (2018-2023) & (K Units)
Table 40. APAC Hemostats and Tissue Sealants Sales Market Share by Region (2018-2023)
Table 41. APAC Hemostats and Tissue Sealants Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Hemostats and Tissue Sealants Revenue Market Share by Region (2018-2023)
Table 43. APAC Hemostats and Tissue Sealants Sales by Type (2018-2023) & (K Units)
Table 44. APAC Hemostats and Tissue Sealants Sales by Application (2018-2023) & (K Units)
Table 45. Europe Hemostats and Tissue Sealants Sales by Country (2018-2023) & (K Units)
Table 46. Europe Hemostats and Tissue Sealants Sales Market Share by Country (2018-2023)
Table 47. Europe Hemostats and Tissue Sealants Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Hemostats and Tissue Sealants Revenue Market Share by Country (2018-2023)
Table 49. Europe Hemostats and Tissue Sealants Sales by Type (2018-2023) & (K Units)
Table 50. Europe Hemostats and Tissue Sealants Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Hemostats and Tissue Sealants Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Hemostats and Tissue Sealants Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Hemostats and Tissue Sealants Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Hemostats and Tissue Sealants Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Hemostats and Tissue Sealants Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Hemostats and Tissue Sealants Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Hemostats and Tissue Sealants
Table 58. Key Market Challenges & Risks of Hemostats and Tissue Sealants
Table 59. Key Industry Trends of Hemostats and Tissue Sealants
Table 60. Hemostats and Tissue Sealants Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Hemostats and Tissue Sealants Distributors List
Table 63. Hemostats and Tissue Sealants Customer List
Table 64. Global Hemostats and Tissue Sealants Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Hemostats and Tissue Sealants Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Hemostats and Tissue Sealants Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Hemostats and Tissue Sealants Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Hemostats and Tissue Sealants Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Hemostats and Tissue Sealants Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Hemostats and Tissue Sealants Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Hemostats and Tissue Sealants Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Hemostats and Tissue Sealants Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Hemostats and Tissue Sealants Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Hemostats and Tissue Sealants Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Hemostats and Tissue Sealants Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Hemostats and Tissue Sealants Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Hemostats and Tissue Sealants Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Baxter Basic Information, Hemostats and Tissue Sealants Manufacturing Base, Sales Area and Its Competitors
Table 79. Baxter Hemostats and Tissue Sealants Product Portfolios and Specifications
Table 80. Baxter Hemostats and Tissue Sealants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Baxter Main Business
Table 82. Baxter Latest Developments
Table 83. CR Bard Basic Information, Hemostats and Tissue Sealants Manufacturing Base, Sales Area and Its Competitors
Table 84. CR Bard Hemostats and Tissue Sealants Product Portfolios and Specifications
Table 85. CR Bard Hemostats and Tissue Sealants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. CR Bard Main Business
Table 87. CR Bard Latest Developments
Table 88. Johnson & Johnson Basic Information, Hemostats and Tissue Sealants Manufacturing Base, Sales Area and Its Competitors
Table 89. Johnson & Johnson Hemostats and Tissue Sealants Product Portfolios and Specifications
Table 90. Johnson & Johnson Hemostats and Tissue Sealants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Johnson & Johnson Main Business
Table 92. Johnson & Johnson Latest Developments
Table 93. B.Braun Basic Information, Hemostats and Tissue Sealants Manufacturing Base, Sales Area and Its Competitors
Table 94. B.Braun Hemostats and Tissue Sealants Product Portfolios and Specifications
Table 95. B.Braun Hemostats and Tissue Sealants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. B.Braun Main Business
Table 97. B.Braun Latest Developments
Table 98. Cardinal Health Basic Information, Hemostats and Tissue Sealants Manufacturing Base, Sales Area and Its Competitors
Table 99. Cardinal Health Hemostats and Tissue Sealants Product Portfolios and Specifications
Table 100. Cardinal Health Hemostats and Tissue Sealants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Cardinal Health Main Business
Table 102. Cardinal Health Latest Developments
Table 103. Cryolife Basic Information, Hemostats and Tissue Sealants Manufacturing Base, Sales Area and Its Competitors
Table 104. Cryolife Hemostats and Tissue Sealants Product Portfolios and Specifications
Table 105. Cryolife Hemostats and Tissue Sealants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Cryolife Main Business
Table 107. Cryolife Latest Developments
Table 108. Neomend Basic Information, Hemostats and Tissue Sealants Manufacturing Base, Sales Area and Its Competitors
Table 109. Neomend Hemostats and Tissue Sealants Product Portfolios and Specifications
Table 110. Neomend Hemostats and Tissue Sealants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Neomend Main Business
Table 112. Neomend Latest Developments
Table 113. Vivostat Basic Information, Hemostats and Tissue Sealants Manufacturing Base, Sales Area and Its Competitors
Table 114. Vivostat Hemostats and Tissue Sealants Product Portfolios and Specifications
Table 115. Vivostat Hemostats and Tissue Sealants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Vivostat Main Business
Table 117. Vivostat Latest Developments
Table 118. Z-Medica Basic Information, Hemostats and Tissue Sealants Manufacturing Base, Sales Area and Its Competitors
Table 119. Z-Medica Hemostats and Tissue Sealants Product Portfolios and Specifications
Table 120. Z-Medica Hemostats and Tissue Sealants Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Z-Medica Main Business
Table 122. Z-Medica Latest Developments
List of Figures
Figure 1. Picture of Hemostats and Tissue Sealants
Figure 2. Hemostats and Tissue Sealants Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hemostats and Tissue Sealants Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Hemostats and Tissue Sealants Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hemostats and Tissue Sealants Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Hemostats
Figure 10. Product Picture of Tissue Sealants
Figure 11. Global Hemostats and Tissue Sealants Sales Market Share by Type in 2022
Figure 12. Global Hemostats and Tissue Sealants Revenue Market Share by Type (2018-2023)
Figure 13. Hemostats and Tissue Sealants Consumed in Clinical Medicine
Figure 14. Global Hemostats and Tissue Sealants Market: Clinical Medicine (2018-2023) & (K Units)
Figure 15. Hemostats and Tissue Sealants Consumed in Scientific Research
Figure 16. Global Hemostats and Tissue Sealants Market: Scientific Research (2018-2023) & (K Units)
Figure 17. Global Hemostats and Tissue Sealants Sales Market Share by Application (2022)
Figure 18. Global Hemostats and Tissue Sealants Revenue Market Share by Application in 2022
Figure 19. Hemostats and Tissue Sealants Sales Market by Company in 2022 (K Units)
Figure 20. Global Hemostats and Tissue Sealants Sales Market Share by Company in 2022
Figure 21. Hemostats and Tissue Sealants Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Hemostats and Tissue Sealants Revenue Market Share by Company in 2022
Figure 23. Global Hemostats and Tissue Sealants Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Hemostats and Tissue Sealants Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Hemostats and Tissue Sealants Sales 2018-2023 (K Units)
Figure 26. Americas Hemostats and Tissue Sealants Revenue 2018-2023 ($ Millions)
Figure 27. APAC Hemostats and Tissue Sealants Sales 2018-2023 (K Units)
Figure 28. APAC Hemostats and Tissue Sealants Revenue 2018-2023 ($ Millions)
Figure 29. Europe Hemostats and Tissue Sealants Sales 2018-2023 (K Units)
Figure 30. Europe Hemostats and Tissue Sealants Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Hemostats and Tissue Sealants Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Hemostats and Tissue Sealants Revenue 2018-2023 ($ Millions)
Figure 33. Americas Hemostats and Tissue Sealants Sales Market Share by Country in 2022
Figure 34. Americas Hemostats and Tissue Sealants Revenue Market Share by Country in 2022
Figure 35. Americas Hemostats and Tissue Sealants Sales Market Share by Type (2018-2023)
Figure 36. Americas Hemostats and Tissue Sealants Sales Market Share by Application (2018-2023)
Figure 37. United States Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Hemostats and Tissue Sealants Sales Market Share by Region in 2022
Figure 42. APAC Hemostats and Tissue Sealants Revenue Market Share by Regions in 2022
Figure 43. APAC Hemostats and Tissue Sealants Sales Market Share by Type (2018-2023)
Figure 44. APAC Hemostats and Tissue Sealants Sales Market Share by Application (2018-2023)
Figure 45. China Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Hemostats and Tissue Sealants Sales Market Share by Country in 2022
Figure 53. Europe Hemostats and Tissue Sealants Revenue Market Share by Country in 2022
Figure 54. Europe Hemostats and Tissue Sealants Sales Market Share by Type (2018-2023)
Figure 55. Europe Hemostats and Tissue Sealants Sales Market Share by Application (2018-2023)
Figure 56. Germany Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Hemostats and Tissue Sealants Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Hemostats and Tissue Sealants Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Hemostats and Tissue Sealants Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Hemostats and Tissue Sealants Sales Market Share by Application (2018-2023)
Figure 65. Egypt Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Hemostats and Tissue Sealants Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Hemostats and Tissue Sealants in 2022
Figure 71. Manufacturing Process Analysis of Hemostats and Tissue Sealants
Figure 72. Industry Chain Structure of Hemostats and Tissue Sealants
Figure 73. Channels of Distribution
Figure 74. Global Hemostats and Tissue Sealants Sales Market Forecast by Region (2024-2029)
Figure 75. Global Hemostats and Tissue Sealants Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Hemostats and Tissue Sealants Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Hemostats and Tissue Sealants Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Hemostats and Tissue Sealants Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Hemostats and Tissue Sealants Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の止血剤＆組織シーラント剤市場予測 2023年-2029年] (コード：LP23MY4849)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の止血剤＆組織シーラント剤市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の止血剤＆組織シーリング剤市場予測 2023年-2029年
  • 世界の止血剤・組織用シーリング剤市場2023年-2028年：成長・動向・新型コロナの影響・市場予測
  • 世界の止血剤＆組織シーラント市場2023-2027
  • 世界の止血剤＆組織封鎖剤市場予測2022年-2028年
  • 世界の組織接着剤市場予測 2023年-2029年
  • 世界の組織スキャフォールド市場予測 2023年-2029年
  • 世界の手術用シーラント＆接着剤市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆